Upadacitinib treatment patterns, achievement of treatment targets and maintenance of response in moderate to severe Rheumatoid Arthritis patients in real-world practice (UPHOLD).
Year: 2020
Type: Musculoskeletal
Phase: Post-Market
Indication: Rheumatoid Arthritis
Real World Effectiveness of Upadacitinib on Early and Sustained Pain Control in Radiographic Axial Spondyloarthritis (UPSTAND).
Year: 2021
Type: Musculoskeletal
Phase: Post-Market
Indication: Spondyloarthritis
Single-Arm, Multicenter, Study to Evaluate Safety and Efficacy of Ultra-Low Frequency Spinal Cord Stimulator in Subjects with Painful Diabetic Neuropathy.
Year: 2021
Type: Device
Phase: Pre-Market
Indication: Painful Diabetic Neuropathy
A Randomized, Active-Controlled, Parallel Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis.
Year: 2021
Type: Musculoskeletal
Phase: IIIb, IV
Indication: Rheumatoid Arthritis
A Multicenter, Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly.
Year: 2019
Type: Vaccine
Phase: III
Indication: Healthy
A Randomized, Double-blind, Placebo-controlled Phase 2b Study to Assess the Efficacy, Immunogenicity and Safety of an Ad26.RSV.preF-based Regimen in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older.
Year: 2019
Type: Vaccine
Phase: IIb
Indication: Healthy
A Randomized, Double-Blind, Placebo- Controlled, Multicentre Phase III Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for12 weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults taking Opioid Therapy for Persistent Non-Cancer Pain.
Year: 2006
Type: Pharmaceutical - Pain
Phase: III
Indication: Pain - General
A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain (RELIEF-2).
Year: 2019
Type: Device
Phase: Post-Market
Indication: Back and/or Leg Pain, Chronic Trunk and/or Limb Pain, Neck / Upper Limb Pain
A Multicenter Open-Label Study Of Etanercept Withdrawal And Retreatment In Subjects With Non-Radiographic Axial Spondyloarthritis Who Achieved Adequate 24 Week Response.
Year: 2016
Type: Musculoskeletal
Phase: IV
Indication: Spondyloarthritis
A Phase 3b/4 Randomized Double-Blind Placebo Controlled Study Of Methotrexate (Mtx) Withdrawal In Subjects With Rheumatoid Arthritis (Ra) Treated With Tofacitinib 11mg Modified Release (Mr) Formulation.
